Skip to content

Author

Wei Xiong

We have 3 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

FANCD2 knockdown suppresses malignant phenotypes and is associated with caspase/PARP-mediated apoptosis in NCI-H2052 pleural mesothelioma cells

Evaluating FANCD2 expression and its clinical associations in PM and the effects of transient FANCD2 knockdown in NCI-H2052 cells demonstrated that FANCD2 was significantly upregulated in PM tissues relative to normal control samples, suggesting that FANCD2 may contribute to PM progression by supporting malignant pheno...

Ying-Fang Xiang, Pu Su, Rui-Ying Zhang et al. · 0 citations
Review Oct 2026

Emerging roles of long non-coding RNA CASC2 in tumor chemoresistance - a review.

Malignant tumors remain a leading cause of global mortality, and the development of chemoresistance represents a major obstacle to effective cancer treatment. Long non-coding RNAs (lncRNAs) are important regulators of tumor progression and therapeutic response. Cancer susceptibility candidate 2 (CASC2) is an lncRNA tha...

Ling-Yun Zhou, Jin-Tao He, Wen-Bing Huang et al. · 0 citations
Review Open access Sep 2026

Long non-coding RNA GAS6-AS1 and its molecular mechanisms in human cancer (Review)

GAS6-AS1 represents a promising molecule for understanding cancer pathogenesis and developing novel strategies for precision cancer diagnosis and treatment, although further clinical validation and mechanistic studies are still required.

Zhi-Ling Lu, Wen-Bing Huang, Jin-Tao He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.